I'm looking forward to the release of the latest full trial results any day now and hoping they're as great as the initial results. Combined with positive FDA device designation a little later in the month it should provide plenty for Ethical to sell into well before the commercial partner announcement.
I'm still very positive on the potential of the partnership deal and think it'll be very impressive, but short term it'll be a nuisance if Ethical still have a few million extras to trade come that ann. Without them forced selling it'll be a MAJOR squeeze if the outcome is as good as many of us are expecting.
Regards
DYOR GLTA
TIS Price at posting:
45.0¢ Sentiment: LT Buy Disclosure: Held
